News & Events
News & Events
February 20, 2023
3rd PSTC Japan Safety Biomarker WorkshopC-Path’s Predictive Safety Testing Consortium is delighted to announce the 3rd PSTC Japan Safety Biomarker Workshop to be held February 20, 2023 in Fujisawa, Japan. The utilization of biomarkers in guiding drug development decisions through clinical trials and post marketing studies is increasing. This conference will explore the areas of cooperation in the clinical applicaton of biomarkers...
February 8, 2023
Webinar: TRxA 2023 Funding Opportunities
C-Path’s Translational Therapeutics Accelerator is a global drug discovery support program that leverages C-Path’s proficiency in translational and regulatory science to bridge the drug development “valley of death.” TRxA accomplishes this by providing academic researchers with funding and guidance to define optimal strategies to advance cutting-edge new therapeutics from the lab to clinical trials and, ultimately, patient care.
January 25, 2023
C-Path Receives Letter of Support from EMA on Duchenne Muscular Dystrophy Clinical Trial Simulation Platform
C-Path today announced that the European Medicines Agency (EMA) has issued a letter of support for the Duchenne Regulatory Science Consortium’s (D-RSC) Model-based Clinical Trial Simulation Platform for Duchenne Muscular Dystrophy (DMD).
January 23, 2023
C-Path and Mobilise-D Collaborate to Improve Impact on the Organizations’ Common GoalsCritical Path Institute is pleased to announce the recent collaboration agreement between C-Path and Mobilise-D. By combining C-Path’s unique global regulatory expertise and Mobilise-D’s focus on digital assessment of mobility, this mutually beneficial partnership aims to accelerate and improve the impact of these important initiatives that share common goals. The Critical Path for...
January 21, 2023 - January 24, 2023
2023 Critical Care CongressJanuary 21-24, 2023 Moscone Center South in San Francisco, California Explore the latest knowledge and research in critical care and network with experts, colleagues, and peers. C-Path’s Smitty Heavner will present, “Leveraging the SCCM Discovery VIRUS COVID-19 Registry to Evaluate Drug Repurposing Research Dataset.” Link: https://www.sccm.org/Congress